InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hoffmann Bernhard. Officer active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 5 reports have been recorded. Activity tracked since 10 January 2023. The latest transaction was disclosed on 13 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Hoffmann Bernhard is a declarant linked to Ocuphire Pharma, Inc. and Opus Genetics, Inc., where he is SVP of Corp. Dev. He has 5 filings in total. In the sampled recent filings, the period runs from 2023-01-12 to 2025-03-17, with buy and sell amounts shown as EUR 0, and the most frequent transaction nature is Attribution.